Table 2.
Impact of the Alpha-ESHRE Consensus on the attitude of IVF centres towards oocytes affected by SERa
| Since the publication of the Alpha-ESHRE Consensus in 2011 concerning embryo assessment (Human Reproduction, Vol 26, No 6, pp. 1270) has your centre’s attitude changed towards the fate of SERa+ oocytes? If yes, in what way? (several answers possible) | 56/118 centres answered yes | |
|---|---|---|
| n / 56 answers | % | |
| We now discard SERa+ oocytes prior to ICSI | 14/56 | 25.0 |
| We now record data and follow up SERa+ oocytes individually | 30/56 | 53.6 |
| We now inform patients about the possible negative outcome of the presence of SERa | 15/56 | 26.8 |
| We now ask patients consent prior to transfer of SERa+ embryos | 6/56 | 10.7 |
| We now record and follow the data of SERa+ oocytes until birth | 9/56 | 16.1 |
| We now transfer SERa+ embryos if there are no other embryos or embryos of sufficient quality for transfer | 30/56 | 53.6 |
| I don’t know | 0/56 | 0.0 |
| Other (explain) | 3/56 | 5.4 |